Advertisement
Research Article| Volume 4, ISSUE 4, P683-702, December 1984

Hypercortisolism

      This paper is only available as a PDF. To read, Please Download here.
      The diagnostic evaluation of a patient with hypercortisolism should progress through screening and then confirmatory hormonal measurements. However, tests of the hypothalamic-pituitary-adrenal axis to predict the cause of hypercortisolism always should be viewed as providing supportive data, as exceptions that occur limit the usefulness of these tests. Familiarity with the diagnostic errors of the procedures is essential.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Ashcraft M.W.
        • Van Herle A.J.
        • Vener S.L.
        • et al.
        Serum cortisol levels in Cushing’s syndrome after low- and high-dose dexamethsone suppression.
        Ann. Intern. Med. 1982; 97: 21-26
        • Axelrod J.
        • Reisine T.D.
        Stress hormones: Their interaction and regulation.
        Science. 1984; 224: 452-459
        • Baker J.
        • Holdaway I.M.
        • Jagusch M.
        • et al.
        Ectopic secretion of ACTH and metenkephalin from a thymic carcinoid.
        J. Endocrinol. Invest. 1982; 5: 33-37
        • Barragry J.M.
        • Mason A.S.
        • Seamark D.A.
        • et al.
        Defective cortisol binding globulin affinity in association with adrenal hyperfunction: A case report.
        Acta Endocrinol. 1980; 95: 194-197
        • Besser G.M.
        • Edwards C.R.W.
        Cushing’s syndrome.
        Clin. Endocrinol. Metab. 1972; 1: 451-490
        • Bertagna C.
        • Orth D.N.
        Clinical and laboratory findings and results of therapy in 58 patients with adrenocortical tumors admitted to a single medical center (1951 to 1978).
        Am. J. Med. 1981; 71: 855-875
        • Caldarella A.M.
        • Reardon G.E.
        • Canalis E.
        Analysis for cortisol in serum by liquid chromatography.
        Clin. Chem. 1982; 28: 538-543
        • Carey R.M.
        • Varma S.K.
        • Drake Jr., C.R.
        • et al.
        Ectopic secretion of corticotropin releasing factor as a cause of Cushing’s syndrome.
        N. Engl. J. Med. 1984; 311: 13-20
        • Caro J.F.
        • Meikle A.W.
        • Check J.H.
        • et al.
        “Normal suppression” to dexamethasone in Cushing’s disease: An expression of decreased metabolic clearance for dexamethasone.
        J. Clin. Endocrinol. Metab. 1978; 47: 667-670
        • Chrousos G.P.
        • Schulte H.M.
        • Oldfield E.H.
        • et al.
        The corticotropin-releasing factor stimulation test.
        N. Engl. J. Med. 1984; 310: 662-666
        • Clerico A.
        • Del Chicca M.G.
        • Zucchelli G.
        • et al.
        Free-cortisol assay by immuno-extraction: Comparison with an equilibrium dialysis procedure.
        Clin. Chem. 1982; 28: 1343-1345
        • Cousins L.
        • Rigg L.
        • Hollingsworth D.
        • et al.
        Qualitative and quantitative assessment of the circadian rhythm of cortisol in pregnancy.
        Am. J. Obstet. Gynecol. 1983; 145: 411-415
        • Crapo L.
        Cushing’s syndrome: A review of diagnostic tests.
        Metabolism. 1979; 28: 955-977
        • Cushing H.
        The basophil adenomas of the pituitary body and their clinical manifestation (pituitary basophilism).
        Bull. Johns Hopkins Hosp. 1932; 50: 137-195
        • Eddy R.L.
        • Jones A.L.
        • Gilliland P.F.
        • et al.
        Cushing’s syndrome: A prospective study of diagnostic methods.
        Am. J. Med. 1973; 55: 621-628
        • Feek C.M.
        • Bevan J.S.
        • Ratcliffe J.G.
        • et al.
        The short metyrapone test: Comparison of the plasma ACTH response to metyrapone with the cortisol response to insulin-induced hypoglycemia in patients with pituitary disease.
        Clin. Endocrinol. 1981; 15: 75-80
        • Feek C.M.
        • Marante D.J.
        • Edwards C.R.W.
        The hypothalamic-pituitary-adrenal axis.
        Clin. Endocrinol. Metab. 1982; 12: 597-618
        • Findling J.W.
        • Aron D.C.
        • Tyrrell J.B.
        • et al.
        Selective venous sampling for ACTH in Cushing’s syndrome.
        Ann. Intern. Med. 1981; 94: 647-652
        • Follenius M.
        • Brandenberger G.
        • Hietter B.
        • et al.
        Diurnal cortisol peaks and their relationships to meals.
        J. Clin. Endocrinol. Metab. 1982; 55: 757-761
        • Garcia M.M.
        Immunoassay measurement of corticotropin (ACTH) and corticotropin releasing factor (CRF).
        J. Clin. Immunoassay. 1983; 6: 291-295
        • Gerwirtz G.
        • Schneider B.
        • Krieger D.T.
        • et al.
        Big ACTH: Conversion to biologically active ACTH by trypsin.
        J. Clin. Endocrinol. Metab. 1974; 38: 227-230
        • Gold E.M.
        The Cushing syndromes: Changing views of diagnosis and treatment.
        Ann. Intern. Med. 1979; 90: 829-843
        • Gold E.M.
        Cushing syndrome: A tripartite entity.
        in: Krieger D.T. Hughes J.C. Neuroendocrinology. Inc., Sinauer Assoc.1980
        • Hardy J.
        Cushing’s disease: 50 years later.
        Can. J. Neurol. Sei. 1982; 9: 375-380
        • Horrocks P.M.
        • London D.R.
        Diagnostic value of the 9 am plasma adrenocorticotropino hormone concentrations in Cushing’s disease.
        Br. Med. J. 1982; 285: 1302-1303
        • Howanitz J.H.
        • Howanitz P.J.
        Evaluation of endocrine function.
        in: Henry J.B. Clinical Diagnosis and Management by Laboratory Methods. 17th ed. W. B. Saunders Co., Philadelphia1984: 322
        • Jezyk P.D.
        • Dauphinais R.M.
        Cortisol specificity by immunoassay and HPLC before and after metyrapone.
        J. Clin. Immunoassay. 1983; 6: 296-301
        • Krieger D.T.
        • Allen W.
        • Rizzo F.
        • et al.
        Characterization of the normal temporal pattern of plasma corticosteroid levels.
        J. Clin. Endocrinol. Metab. 1971; 32: 266-284
        • Krieger D.T.
        • Amorosa L.
        • Linick F.
        Cyproheptadine-induced remission of Cushing’s disease.
        N. Engl. J. Med. 1975; 293: 893-896
        • Mattingly D.
        A simple fluorimetric method for the estimation of free 11-hydroxycorticoids in human plasma.
        J. Clin. Pathol. 1962; 15: 374-379
        • McIntosh T.K.
        • Lothrop D.A.
        • Lee A.
        • et al.
        Circadian rhythm of cortisol is altered in postsurgical patients.
        J. Clin. Endocrinol. Metab. 1981; 53: 117-122
        • Meikle A.W.
        Dexamethasone suppression tests: Usefulness of simultaneous measurement of plasma cortisol and dexamethasone.
        Clin. Endocinol. 1982; 16: A01-A08
        • Meikle A.W.
        • Stanchfield J.B.
        • West C.D.
        • et al.
        Hydrocortisone suppression test for Cushing syndrome.
        Arch. Intern. Med. 1974; 134: 1068-1071
        • Müller O.A.
        • Stalla G.K.
        • van Werder K.
        Corticotropin releasing factor: A new tool for the differential diagnosis of Cushing’s syndrome.
        J. Clin. Endocrinol. Metab. 1980; 57: 227-229
        • Murphy B.E.P.
        • Okouneff L.M.
        • Klein G.P.
        • et al.
        Lack of specificity of cortisol determinations in human urine.
        J. Clin. Endocrinol. Metab. 1981; 53: 91-99
        • Nelson J.C.
        • Tindall Jr., D.J.
        A comparison of the adrenal responses to hypoglycemia, metyrapone and ACTH.
        Am. J. Med. 1978; 275: 165-172
        • Newsome Jr., H.H.
        • Clements A.S.
        • Borum E.H.
        The simultaneous assay of cortisol, corticosterone, 11-deoxycortisol, a cortisone in human plasma.
        J. Clin. Endocrinol. Metab. 1972; 34: 473-483
        • Nichols T.
        • Nugent C.A.
        • Tyler F.H.
        Steroid laboratory tests in the diagnosis of Cushing’s syndrome.
        Am. J. Med. 1968; 45: 116-128
        • Nicholson W.E.
        • Davis D.R.
        • Sherrell B.J.
        • et al.
        Rapid radioimmunoassay for corticotropin in unextracted human plasma.
        Clin. Chem. 1984; 30: 259-265
        • Nicolis G.L.
        • Mitty H.A.
        • Modlinger R.S.
        • et al.
        Percutaneous adrenal venography.
        Ann. Intern. Med. 1972; 76: 899-909
        • Nolan G.E.
        • Smith J.B.
        • Chavre V.J.
        • et al.
        Spurious overestimation of plasma cortisol in patients with chronic renal failure.
        J. Clin. Endocrinol. Metab. 1981; 52: 1242-1245
        • Orth D.N.
        • DeBold C.R.
        • DeCherney G.S.
        • et al.
        Pituitary microadenomas causing Cushing’s disease respond to corticotropin-releasing factor.
        J. Clin. Endocrinol. Metab. 1982; 55: 1017-1019
        • Porter C.C.
        • Silber R.H.
        A quantitative color reaction for cortisone and related 17,21-dihydroxy-20-ketosteroids.
        J. Biol. Chem. 1950; 185: 201-207
        • Ratcliffe J.G.
        • Podmore J.
        • Stack B.H.R.
        • et al.
        Circulating ACTH and related peptides in lung cancer.
        Br. J. Cancer. 1982; 45: 230-236
        • Ratter S.J.
        • Lowry P.J.
        • Besser G.M.
        • et al.
        Chromatographic characterization of adrenocorticotropin in human plasma.
        J. Endocrinol. 1980; 85: 359-369
        • Sindler B.H.
        • Griffing G.T.
        • Melby J.C.
        The superiority of the metyrapone test versus the high-dose dexamethasone test in the differential diagnosis of Cushing’s syndrome.
        Am. J. Med. 1983; 74: 657-662
        • Spiger M.
        • Jubiz W.
        • Meikle A.W.
        • et al.
        Single-dose metyrapone test.
        Arch. Intern. Med. 1975; 135: 698-700
        • Staub J.J.
        • Noelpp B.
        • Girard J.
        • et al.
        The short metyrapone test: Comparison of the plasma ACTH response to metyrapone and insulin-induced hypoglycemia.
        Clin. Endocrinol. 1979; 10: 595-601
        • Streeten D.H.P.
        • Dalakos T.G.
        • Anderson Jr., G.H.
        Diagnosis and treatment of Cushing’s syndrome.
        in: Rose L.I. Lavine R.L. The Thirty-Ninth Hahnemann Endocrinology Metabolism Symposium. Grune and Stratton, New York1976
        • Tan S.Y.
        • Donabedian R.
        • Genei M.
        • et al.
        False elevation of plasma cortisol in congenital adrenal hyperplasia.
        J. Clin. Lab. Med. 1977; 89: 735-740
        • Van Baelen H.
        • Brepoels R.
        • De Moore P.
        Transcortin Leuven: A variant of human corticosteroid-binding globulin with decreased cortisol-binding affinity.
        J. Biol. Chem. 1982; 257: 3397-3400
        • Yalow R.S.
        • Berson S.A.
        Characteristics of “Big ACTH” in human plasma and pituitary extracts.
        J. Clin. Endocrinol. Metab. 1973; 36: 415-423
        • Zadik Z.
        • De Lacerda L.
        • De Carmargo L.A.H.
        • et al.
        A comparative study of urinary 17-hydroxycorticosteroids, urinary free cortisol, and the integrated concentration of plasma cortisol.
        J. Clin. Endocrinol. Metab. 1980; 51: 1099-1101